|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith RA, Manassaram-Baptiste D, Brooks D,
Doroshenk M, Fedewa S, Saslow D, Brawley OW and Wender R: Cancer
screening in the United States, 2015: A review of current American
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 65:30–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Novaes FT, Cataneo DC, Ruiz RL Jr,
Defaveri J, Michelin OC and Cataneo AJ: Lung cancer: histology,
staging, treatment and survival. J Bras Pneumol. 34:595–600. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Youlden DR, Cramb SM and Baade PD: The
International Epidemiology of lung cancer: Geographical
distribution and secular trends. J Thorac Oncol. 3:819–831. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnson JL, Pillai S and Chellappan SP:
Genetic and biochemical alterations in non-small cell lung cancer.
Biochem Res Int. 2012:9404052012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ginsberg RJ and Rubinstein LV: Randomized
trial of lobectomy versus limited resection for T1 N0 non-small
cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg.
60:615–622; discussion 622–613. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Timmerman R, Paulus R, Galvin J, Michalski
J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone
D, et al: Stereotactic body radiation therapy for inoperable early
stage lung cancer. JAMA. 303:1070–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chi A, Liao Z, Nguyen NP, Xu J, Stea B and
Komaki R: Systemic review of the patterns of failure following
stereotactic body radiation therapy in early-stage non-small-cell
lung cancer: clinical implications. Radiother Oncol. 94:1–11. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martini N, Bains MS, Burt ME, Zakowski MF,
McCormack P, Rusch VW and Ginsberg RJ: Incidence of local
recurrence and second primary tumors in resected stage I lung
cancer. J Thorac Cardiovasc Surg. 109:120–129. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP and Chen CZ: Micromanagers of
gene expression: The potentially widespread influence of metazoan
microRNAs. Nat Rev Genet. 5:396–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar
|
|
14
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang S, Lu Z, Unruh AK, Ivan C, Baggerly
KA, Calin GA, Li Z, Bast RC Jr and Le XF: Clinically relevant
microRNAs in ovarian cancer. Mol Cancer Res. 13:393–401. 2015.
View Article : Google Scholar :
|
|
16
|
Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang
Y, Gu Q, Dong X, Liu F, Zhang Y, et al: miR-27a-3p suppresses tumor
metastasis and VM by down-regulating VE-cadherin expression and
inhibiting EMT: An essential role for Twist-1 in HCC. Sci Rep.
6:230912016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gomes BC, Santos B, Rueff J and Rodrigues
AS: Methods for studying MicroRNA expression and their targets in
formalin-fixed, paraffin-embedded (FFPE) breast cancer tissues.
Methods Mol Biol. 1395:189–205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim G, An HJ, Lee MJ, Song JY, Jeong JY,
Lee JH and Jeong HC: Hsa-miR-1246 and hsa-miR-1290 are associated
with stemness and invasiveness of non-small cell lung cancer. Lung
Cancer. 91:15–22. 2016. View Article : Google Scholar
|
|
19
|
Zhang Y, Li M, Wang H, Fisher WE, Lin PH,
Yao Q and Chen C: Profiling of 95 microRNAs in pancreatic cancer
cell lines and surgical specimens by real-time PCR analysis. World
J Surg. 33:698–709. 2009. View Article : Google Scholar
|
|
20
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar
|
|
21
|
Erdmann K, Kaulke K, Thomae C, Huebner D,
Sergon M, Froehner M, Wirth MP and Fuessel S: Elevated expression
of prostate cancer-associated genes is linked to down-regulation of
microRNAs. BMC Cancer. 14:82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai J, Wu J, Zhang H, Fang L, Huang Y,
Yang Y, Zhu X, Li R and Li M: miR-186 downregulation correlates
with poor survival in lung adenocarcinoma, where it interferes with
cell-cycle regulation. Cancer Res. 73:756–766. 2013. View Article : Google Scholar
|
|
23
|
Cui G, Cui M, Li Y, Liang Y, Li W, Guo H
and Zhao S: MiR-186 targets ROCK1 to suppress the growth and
metastasis of NSCLC cells. Tumour Biol. 35:8933–8937. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ruan WD, Wang P, Feng S, Xue Y and Zhang
B: MicroRNA-497 inhibits cell proliferation, migration, and
invasion by targeting AMOT in human osteosarcoma cells. Onco
Targets Ther. 9:303–313. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Liu G, Li Q, Wang F, Xie F, Zhai
R, Guo Y, Chen T, Zhang N, Ni W, et al: Mucin1 promotes the
migration and invasion of hepatocellular carcinoma cells via
JNK-mediated phosphorylation of Smad2 at the C-terminal and linker
regions. Oncotarget. 6:19264–19278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tian L, Fang YX, Xue JL and Chen JZ: Four
microRNAs promote prostate cell proliferation with regulation of
PTEN and its downstream signals in vitro. PLoS One. 8:e758852013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hauser B, Zhao Y, Pang X, Ling Z, Myers E,
Wang P, Califano J and Gu X: Functions of MiRNA-128 on the
regulation of head and neck squamous cell carcinoma growth and
apoptosis. PLoS One. 10:e01163212015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lv SQ, Kim YH, Giulio F, Shalaby T,
Nobusawa S, Yang H, Zhou Z, Grotzer M and Ohgaki H: Genetic
alterations in microRNAs in medulloblastomas. Brain Pathol.
22:230–239. 2012. View Article : Google Scholar
|
|
30
|
Su B, Cheng J, Yang J and Guo Z: MEKK2 is
required for T-cell receptor signals in JNK activation and
interleukin-2 gene expression. J Biol Chem. 276:14784–14790. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chayama K, Papst PJ, Garrington TP, Pratt
JC, Ishizuka T, Webb S, Ganiatsas S, Zon LI, Sun W, Johnson GL, et
al: Role of MEKK2-MEK5 in the regulation of TNF-alpha gene
expression and MEKK2-MKK7 in the activation of c-Jun N-terminal
kinase in mast cells. Proc Natl Acad Sci USA. 98:4599–4604. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schaefer BC, Ware MF, Marrack P, Fanger
GR, Kappler JW, Johnson GL and Monks CR: Live cell fluorescence
imaging of T cell MEKK2: Redistribution and activation in response
to antigen stimulation of the T cell receptor. Immunity.
11:411–421. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun W, Wei X, Kesavan K, Garrington TP,
Fan R, Mei J, Anderson SM, Gelfand EW and Johnson GL: MEK kinase 2
and the adaptor protein Lad regulate extracellular signal-regulated
kinase 5 activation by epidermal growth factor via Src. Mol Cell
Biol. 23:2298–2308. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cazares LH1, Troyer D, Mendrinos S, Lance
RA, Nyalwidhe JO, Beydoun HA, Clements MA, Drake RR and Semmes OJ:
Imaging mass spectrometry of a specific fragment of
mitogen-activated protein kinase/extracellular signal-regulated
kinase kinase kinase 2 discriminates cancer from uninvolved
prostate tissue. Clin Cancer Res. 15:5541–5551. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Kong G, Zhang J, Wang T, Ye L and
Zhang X: MicroRNA-520b inhibits growth of hepatoma cells by
targeting MEKK2 and cyclin D1. PLoS One. 7:e314502012. View Article : Google Scholar : PubMed/NCBI
|
